Functional Assessment of Cancer Therapy - Lymphoma (FACT-Lym)

Hlubocky FJ; Webster K; Cashy J; Beaumont J; Cella D


Basic description

  • Developed in 2005
  • The FACT-Lym is composed of the FACT-G plus the 15-item Lymphoma Subscale (LymS)

Hlubocky FJ; Webster K; Cashy J; Beaumont J; Cella D

FACT-Lym© David Cella, 1987,1997. All rights reserved. Questionnaires and all related subscales, translations, and adaptations are owned and copyrighted by David Cella.
To address health-related quality-of-life (HRQL) issues for Non-Hodgkin’s lymphoma (NHL) patients
Therapeutic area
  • Neoplasms
  • Hemic and Lymphatic Diseases
  • Immune System Diseases
  • Rare disease (Orphanet definition)
Therapeutic indication

Lymphoma, Non-Hodgkin For more information on this rare disease, please consult the following link: Orphanet page

Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English
53 translation(s)
Bibliographic reference(s) of the original questionnaire

Hlubocky FJ, Webster K, Beaumont J, Cashy J, Paul D, Abernethy A, Syrjala KL, Von Roenn J, Cella D. A preliminary study of a health related quality of life assessment of priority symptoms in advanced lymphoma: the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy - Lymphoma Symptom Index. Leuk Lymphoma. 2013 Sep;54(9):1942-6 (PubMed abstract)

Webster K., Cashy J., Cella D. et al. Measuring quality of life (QOL) in patients with non-Hodgkin’s lymphoma (NHL): the Functional Assessment of Cancer Therapy-Lymphoma (FACT-Lym). Qual Life Res 2005, 14:1650

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us